JPWO2023063284A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023063284A5
JPWO2023063284A5 JP2023554511A JP2023554511A JPWO2023063284A5 JP WO2023063284 A5 JPWO2023063284 A5 JP WO2023063284A5 JP 2023554511 A JP2023554511 A JP 2023554511A JP 2023554511 A JP2023554511 A JP 2023554511A JP WO2023063284 A5 JPWO2023063284 A5 JP WO2023063284A5
Authority
JP
Japan
Prior art keywords
cells
secretion
promoting
extracellular vesicle
extracellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023554511A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023063284A1 (https=
JP7825631B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/037768 external-priority patent/WO2023063284A1/ja
Publication of JPWO2023063284A1 publication Critical patent/JPWO2023063284A1/ja
Publication of JPWO2023063284A5 publication Critical patent/JPWO2023063284A5/ja
Application granted granted Critical
Publication of JP7825631B2 publication Critical patent/JP7825631B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023554511A 2021-10-11 2022-10-11 細胞外小胞の分泌を促進する細胞外小胞分泌促進剤、およびその用途 Active JP7825631B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021166634 2021-10-11
JP2021166634 2021-10-11
PCT/JP2022/037768 WO2023063284A1 (ja) 2021-10-11 2022-10-11 細胞外小胞の分泌を促進する細胞外小胞分泌促進剤、およびその用途

Publications (3)

Publication Number Publication Date
JPWO2023063284A1 JPWO2023063284A1 (https=) 2023-04-20
JPWO2023063284A5 true JPWO2023063284A5 (https=) 2024-07-01
JP7825631B2 JP7825631B2 (ja) 2026-03-06

Family

ID=85987765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023554511A Active JP7825631B2 (ja) 2021-10-11 2022-10-11 細胞外小胞の分泌を促進する細胞外小胞分泌促進剤、およびその用途

Country Status (4)

Country Link
US (1) US20250270564A1 (https=)
EP (1) EP4417693A1 (https=)
JP (1) JP7825631B2 (https=)
WO (1) WO2023063284A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6083534B2 (ja) * 2012-02-08 2017-02-22 国立研究開発法人産業技術総合研究所 マラリアの予防または治療薬及びそのスクリーニング方法
WO2020204161A1 (ja) * 2019-04-04 2020-10-08 日産化学株式会社 細胞外小胞の分泌を促進するための組成物
JP7691113B2 (ja) * 2019-11-15 2025-06-11 国立大学法人 東京大学 バーコード化された細胞外小胞のライブラリー
JP2021166634A (ja) 2020-04-10 2021-10-21 株式会社アイシン 車両用シート装置

Similar Documents

Publication Publication Date Title
JP7720384B2 (ja) 低分子干渉核酸（ｓｉＮＡ）を用いたカテニン（カドヘリン結合型タンパク質）β１（ＣＴＮＮＢ１）遺伝子発現のＲＮＡ干渉媒介性阻害
Xiao et al. LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4
Bonnet et al. Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases
JP2018088923A (ja) 線維症予防又は治療剤
KR20230035135A (ko) 라미닌 511 생성 촉진제, 표피 기저막 안정화제 및/또는 표피 줄기 세포 감소 억제 또는 증가 촉진제의 스크리닝 방법
Lin et al. LncRNA-XIST promotes dermal papilla induced hair follicle regeneration by targeting miR-424 to activate hedgehog signaling
Taga et al. miR-486-5p inhibits invasion and migration of HTR8/SVneo trophoblast cells by down-regulating ARHGAP5
Ma et al. Cardiac over-expression of microRNA-1 induces impairment of cognition in mice
JP2025521615A (ja) 脂質構造及びそれを含む組成物
CN104726500B (zh) MicroRNA26b‑3p抑制剂在制备人脐带来源间充质干细胞中的应用
CN121868329A (zh) 减轻缺血再灌注损伤的合成物和方法
Hao et al. tRNA-derived small RNA (tsr007330) regulates myocardial fibrosis after myocardial infarction through NAT10-mediated ac4C acetylation of EGR3 mRNA
Yu et al. METTL14-mediated m6A methylation of pri-miR-5099 to facilitate cardiomyocyte pyroptosis in myocardial infarction
JPWO2023063284A5 (https=)
CN112933112B (zh) 氧化石墨烯或其调控分子在制备促进糖尿病创面修复的药物中的应用
CN101705227B (zh) 抑制人AP-2alpha基因表达的siRNA在抗宫颈癌药物制备中的应用
KR102552776B1 (ko) miRNA를 포함하는 흑색종 전이 억제용 조성물
Liu et al. ZEB1-AS1 AS a TRPML1 inhibitor to cause lysosome dysfunction and cardiac damage in aged mice
JP5850702B2 (ja) 間葉系細胞の分化調節剤およびこれを用いた医薬、並びに間葉系細胞への分化調節作用を有する物質のスクリーニング方法
KR20220029656A (ko) Atoh1 유전자를 활성화하는 올리고머 핵산 분자 및 그의 이용
US11512316B2 (en) Enhanced organogenesis through manipulation of LIN28/LET-7/DIS3L2
CN116407636B (zh) Lnc-CCKAR-5在制备促进糖尿病创面修复的药物中的应用
EP4279091A1 (en) Composition comprising mir 145 inhibitor as active ingredient for treatment of myocardial infarction
Alcharani et al. Identification of miR‐150‐5p in Human Amniotic Membrane Mesenchymal Cell‐Derived Extracellular Vesicles as a Novel Mechanism Driving Cardioprotection
Qian et al. LncRNA TUG1 mitigates renal interstitial fibrosis through miR-542-3p/HIF-1α/VEGF axis